4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0001209191-18-039887
Options or other derivatives
- Director acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| KOCH KEVIN Director | 2018-06-27 | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | D | ||
Loading xslF345X03/doc4.xml…